These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 10877737)

  • 1. Failure to develop HIV infection after receipt of HIV-contaminated blood and postexposure prophylaxis.
    Katzenstein TL; Dickmeiss E; Aladdin H; Hede A; Nielsen C; Nielsen H; Jørgensen LB; Gerstoft J
    Ann Intern Med; 2000 Jul; 133(1):31-4. PubMed ID: 10877737
    [No Abstract]   [Full Text] [Related]  

  • 2. Report updates recommendations for health workers exposed to HIV.
    Am J Health Syst Pharm; 1998 Sep; 55(17):1755. PubMed ID: 9867409
    [No Abstract]   [Full Text] [Related]  

  • 3. Tolerability of postexposure prophylaxis with zidovudine, lamivudine, and nelfinavir for human immunodeficiency virus infection.
    Rabaud C; Bevilacqua S; Beguinot I; Dorvaux V; Schuhmacher H; May T; Canton P
    Clin Infect Dis; 2001 May; 32(10):1494-5. PubMed ID: 11317252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV postexposure prophylaxis: new recommendations.
    Patrick DM
    CMAJ; 1997 Jan; 156(2):233-4. PubMed ID: 9012728
    [No Abstract]   [Full Text] [Related]  

  • 5. Summaries for patients. Predictors of outcomes in patients with HIV infection treated with indinavir, zidovudine, and lamivudine.
    Ann Intern Med; 2001 Dec; 135(11):S-59. PubMed ID: 11759663
    [No Abstract]   [Full Text] [Related]  

  • 6. A randomized trial of three maintenance regimens given after three months of induction therapy with zidovudine, lamivudine, and indinavir in previously untreated HIV-1-infected patients. Trilège (Agence Nationale de Recherches sur le SIDA 072) Study Team.
    Pialoux G; Raffi F; Brun-Vezinet F; Meiffrédy V; Flandre P; Gastaut JA; Dellamonica P; Yeni P; Delfraissy JF; Aboulker JP
    N Engl J Med; 1998 Oct; 339(18):1269-76. PubMed ID: 9791142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, controlled trial of indinavir, zidovudine, and lamivudine in adults with advanced human immunodeficiency virus type 1 infection and prior antiretroviral therapy.
    Hirsch M; Steigbigel R; Staszewski S; Mellors J; Scerpella E; Hirschel B; Lange J; Squires K; Rawlins S; Meibohm A; Leavitt R
    J Infect Dis; 1999 Sep; 180(3):659-65. PubMed ID: 10438352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prophylactic antiretroviral therapy after sexual exposure to HIV: 93 cases].
    Timsit FJ; Maillard A; Spindler E; Taquin Y; Deniaud F; Ferchal F; Morel P; Janier M
    Ann Dermatol Venereol; 2002; 129(6-7):866-9. PubMed ID: 12218913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure of postexposure prophylaxis after sexual exposure to HIV.
    Fournier S; Maillard A; Molina JM
    AIDS; 2001 Feb; 15(3):430. PubMed ID: 11273232
    [No Abstract]   [Full Text] [Related]  

  • 10. Chemoprophylaxis after occupational exposure to human immunodeficiency virus in forensic autopsy.
    Kibayashi K; NG'walali PM; Tsunenari S
    Nihon Hoigaku Zasshi; 1998 Apr; 52(2):163-4. PubMed ID: 9711070
    [No Abstract]   [Full Text] [Related]  

  • 11. Maintenance antiretroviral therapies in HIV-infected subjects with undetectable plasma HIV RNA after triple-drug therapy. AIDS Clinical Trials Group Study 343 Team.
    Havlir DV; Marschner IC; Hirsch MS; Collier AC; Tebas P; Bassett RL; Ioannidis JP; Holohan MK; Leavitt R; Boone G; Richman DD
    N Engl J Med; 1998 Oct; 339(18):1261-8. PubMed ID: 9791141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AVANTI 3: a randomized, double-blind trial to compare the efficacy and safety of lamivudine plus zidovudine versus lamivudine plus zidovudine plus nelfinavir in HIV-1-infected antiretroviral-naive patients.
    Gartland M;
    Antivir Ther; 2001 Jun; 6(2):127-34. PubMed ID: 11491417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypercholesterolemia in a health care worker receiving thyroxine after postexposure prophylaxis for human immunodeficiency virus infection.
    Nerad JL; Kessler HA
    Clin Infect Dis; 2001 Jun; 32(11):1635-6. PubMed ID: 11340537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drugs for HIV infection.
    Med Lett Drugs Ther; 1997 Dec; 39(1015):111-6. PubMed ID: 9402928
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy.
    Gulick RM; Mellors JW; Havlir D; Eron JJ; Gonzalez C; McMahon D; Richman DD; Valentine FT; Jonas L; Meibohm A; Emini EA; Chodakewitz JA
    N Engl J Med; 1997 Sep; 337(11):734-9. PubMed ID: 9287228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug shows potency against HIV.
    Dent Today; 1996 May; 15(5):22, 26. PubMed ID: 9567867
    [No Abstract]   [Full Text] [Related]  

  • 17. 3-year suppression of HIV viremia with indinavir, zidovudine, and lamivudine.
    Gulick RM; Mellors JW; Havlir D; Eron JJ; Meibohm A; Condra JH; Valentine FT; McMahon D; Gonzalez C; Jonas L; Emini EA; Chodakewitz JA; Isaacs R; Richman DD
    Ann Intern Med; 2000 Jul; 133(1):35-9. PubMed ID: 10877738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiretroviral rounds. When success is a pain.
    Bartlett JG; del Rio C
    AIDS Clin Care; 2001 Aug; 13(8):74-5. PubMed ID: 11547461
    [No Abstract]   [Full Text] [Related]  

  • 19. Predictors of virologic and clinical outcomes in HIV-1-infected patients receiving concurrent treatment with indinavir, zidovudine, and lamivudine. AIDS Clinical Trials Group Protocol 320.
    Demeter LM; Hughes MD; Coombs RW; Jackson JB; Grimes JM; Bosch RJ; Fiscus SA; Spector SA; Squires KE; Fischl MA; Hammer SM
    Ann Intern Med; 2001 Dec; 135(11):954-64. PubMed ID: 11730396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Needle-stick injuries and HIV infection: a surgeon's personal experience and review of postexposure prophylaxis. St. Paul's Ocular AIDS Group.
    Hurwitz JJ; Fine N; Rachlis AR
    Can J Ophthalmol; 1999 Jun; 34(4):195-203. PubMed ID: 10396655
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.